Not Prosecuting Free Oxygen Suppliers, Drug Controller Tells Delhi HC

New Delhi : The Drugs Control Department informed the Delhi High Court on Thursday that it has decided not to prosecute those who were involved in supplying free oxygen cylinders to COVID-19 patients in the Capital during the second wave of the pandemic.

A Bench of Justices Vipin Sanghi and Jasmeet Singh said the stand taken by the department was the “right approach”. Taking note of the submission, the court also decided to dispose of a petition seeking the lodging of an FIR on allegations that politicians were able to procure COVID medicines in huge quantities and distribute them even as patients were running from pillar to post to get them.

‘No wrongful intention’

Senior advocate Rahul Mehra, representing the Delhi government, said they have decided not to launch any prosecution against social organisations, individuals and gurdwaras which procured and distributed medical oxygen to COVID patients free of cost and without any wrongful intention.

Mr. Mehra said the pandemic is not yet over and if prosecution is launched in such cases, no good Samaritan would come forward in future to help the needy for fear of being punished.

In the previous hearing, the High Court had slammed the drug controller for initiating proceedings against AAP MLA Praveen Kumar for procuring and distributing oxygen cylinders during the second wave.

The court had said it would not permit prosecution of good Samaritans for helping society at a time when the state had failed to provide oxygen.

“If you initiate prosecution like this, you will have to pick up half the gurdwaras, temples, churches and all political parties as well. We won’t allow this,” the court had remarked, adding it was “unfortunate that a tragedy is being used for political capital”.

It, however, drew a distinction between the AAP MLA’s case and that of BJP MP from East Delhi, Gautam Gambhir, who had procured, stocked and distributed a large quantity of medicines to COVID-19 patients. The court remarked that Mr. Gambhir had “irresponsibly hoarded medicines” when people did not have access to them. “Though Mr. Gambhir’s intentions were in the right place, it is not allowed,” the court noted.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India